Commercials - Publications - Faculty & Research - Harvard Business School

Filter Results: (2,563)

Filter Results: (2,563)

Show Results For

← Page 26 of 2,563 Results →

June 2013 (Revised January 2016)
Case

Château Margaux: Launching the Third Wine

By: Elie Ofek and Eric E. Vogt

Château Margaux, one of only five prestigious estates in the Bordeaux Medoc wine region to have been classified as a "first-growth", is facing a host of strategic decisions in early 2013. Up until this point the estate had been selling two red wines, a first wine whose... View Details

Keywords: New Product Launch; Marketing Plan; Brand Management; Go To Market Strategy; Channels Of Distribution; Wine Industry; Marketing Strategy; Distribution Channels; Product Launch; Brands and Branding; Agriculture and Agribusiness Industry; Food and Beverage Industry; France

2016
Working Paper

Android and Competition Law: Exploring and Assessing Google's Practices in Mobile

By: Benjamin Edelman and Damien Geradin

Since its launch in 2007, Android has become the dominant mobile device operating system worldwide. In light of this commercial success and certain disputed business practices, Android has come under substantial attention from competition authorities. We present key... View Details

Keywords: Android; Antitrust; Competition Policy; Exclusion; Mobile Communication Devices; Remedies; Tying; Two-Sided Platforms; Lawfulness; Internet; Mobile Technology; Wireless Technology; Information Technology Industry; Telecommunications Industry

February 2002 (Revised April 2011)
Case

The Future of Hybrid Electric Vehicles

By: John T. Gourville, Alice Tzou and David Lane

Set in 2002, this case looks at the potential for hybrid electric vehicles in the United States. Looks at the pressures on the automotive industry to produce a commercially viable, environmentally friendly vehicle and the consumer behavior surrounding purchase of those... View Details

Keywords: Technological Innovation; Marketing Strategy; Consumer Behavior; Environmental Sustainability; Technology Adoption; Auto Industry; United States

March 2014 (Revised May 2014)
Case

China Vanke (A-1)

By: Lynn S. Paine, John Macomber and Keith Chi-ho Wong

As China's largest homebuilder, China Vanke Co. Ltd. (Vanke) was facing an industry downturn sparked by strong government intervention. Faced with falling prices, Vanke's president must decide whether to keep the company's pricing and product positioning intact, and... View Details

Keywords: Real Estate; China; Green Building; Sustainable Development; Business Government Relations; Leadership; Business and Government Relations; Urban Development; Growth and Development Strategy; Safety; Real Estate Industry; China

December 2006 (Revised February 2009)
Case

China Merchants Bank: Here Just For You

By: F. Warren McFarlan, GuoQing Chen, HengYuan Zhu, Bin Yang, Michael Shih-ta Chen, G.A. Donovan, Waishun Lo and Yan Yang

Founded in 1987, China Merchants Bank (CMB) is a pioneer in the use of technical innovation and IT as a competitive tool in the rapidly evolving Chinese banking sector. With a relatively small branch network when compared to its larger competitors, CMB uses an... View Details

Keywords: Credit Cards; Information Technology; Technological Innovation; Innovation Leadership; Competitive Strategy; Initial Public Offering; Emerging Markets; Opportunities; Banking Industry; China; Hong Kong

March 2005 (Revised May 2011)
Course Overview Note

Conceptual Overview of Real Property

By: Arthur I Segel and Ann Winslow

Real estate represents the largest asset class in the world. Businesses in the United States have over $8.6 trillion of real estate assets on their balance sheets. Excluding housing--worth $16 trillion in the United States--and corporate-owned real estate, there is... View Details

Keywords: Property

April 1993 (Revised May 1994)
Case

Genzyme Corporation: Strategic Challenges with Ceredase

Genzyme Corp., one of the largest biotechnology companies, has succeeded in developing, manufacturing, and commercializing its first therapeutic, a treatment for a rare genetic disease. Analysis of the case requires students to identify and understand how Genzyme has... View Details

Keywords: Risk Management; Risk and Uncertainty; Corporate Strategy; Technology; Health; Product Development; Biotechnology Industry; Pharmaceutical Industry; United States

25 Mar 2016
HBS Seminar

Curtis Keith, Harvard University, Blavatnik Biomedical Accelerator

October 1991 (Revised December 1993)
Case

Ben & Jerry's Homemade Ice Cream, Inc.: Keeping the Mission(s) Alive

Ben & Jerry's is an anti-establishment, values-driven company that has become a successful venture. The dominant founder, Ben Cohen, is not an effective manager, but he brings creative marketing and product skills that have been important to the company's success. He... View Details

Keywords: Mission and Purpose; Organizational Culture; Entrepreneurship; Compensation and Benefits; Manufacturing Industry; Food and Beverage Industry

January 1996
Case

Palm Computing, Inc. (A)

By: Myra M. Hart

Discusses patents, licenses, and deal making in a start-up venture. The entrepreneur, Jeff Hawkins, holds a patent on Palm Print, a pattern recognition algorithm. After licensing Palm Print to his employer, he led three years of development of commercial products for... View Details

Keywords: Intellectual Property; Patents; Agreements and Arrangements; Negotiation Deal; Business Startups; Management Teams

July 1997 (Revised April 1998)
Case

Chase Manhattan Corporation: The Making of America's Largest Bank

By: Stuart C. Gilson and Cedric Escalle

Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details

Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States

December 2008 (Revised October 2013)
Case

Amylin Pharmaceuticals: Diabetes and Beyond (A)

By: Richard G. Hamermesh and Rachel Gordon

Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details

Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States

William A. Sahlman

William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.

Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details

01 Nov 2012
HBS Seminar

Joel Waldfogel, University of Minnesota

January 2006 (Revised July 2016)
Case

Gordon Bethune at Continental Airlines

By: Nitin Nohria, Anthony Mayo and Mark Benson

A $385 million loss for the final months of fiscal year 1994 signaled Continental might go bankrupt. Could new CEO Gordon Bethune turn Continental around? Continental was in dire straits because the deregulation of the commercial airline industry in 1978 ushered in a... View Details

Keywords: Transformation; Insolvency and Bankruptcy; Profit; Leading Change; Organizational Change and Adaptation; Performance Improvement; Labor and Management Relations; Air Transportation Industry

August 2024
Article

How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

By: Leemore S. Dafny, Kate Ho and Edward Kong

Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details

Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States

Find at Harvard

Register to Read

2019
Working Paper

Who Drives Digital Innovation? Evidence from the U.S. Medical Device Industry

By: Cirrus Foroughi and Ariel Dora Stern

Does the large-scale technological change that is characteristic of an industry-wide digital transformation entrench industry leaders or enable the rise of new entrants? We offer a novel approach to this question by studying the medical device industry, a unique... View Details

Keywords: Innovation; Medical Devices; Digitization; Medical Technology; Technological Innovation; Applications and Software; Market Entry and Exit; Industry Growth; Medical Devices and Supplies Industry; United States

2013
Working Paper

How the Zebra Got Its Stripes: Imprinting of Individuals and Hybrid Social Ventures

By: Matthew Lee and Julie Battilana

Hybrid organizations that combine multiple, existing organizational forms are frequently proposed as a source of organizational innovation, yet little is known about the origins of such organizations. We propose that individual founders of hybrid organizations acquire... View Details

Keywords: Hybrid Organizations; Imprinting; Institutional Theory; Social Entrepreneurship; Organizations

How Do Drug Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details

March 1994
Case

Fremont Financial Corporation (A)

Fremont Financial is an asset-based lender to middle-market companies. This case considers two options for Fremont to raise capital to finance its loan portfolio. Fremont can: 1) extend its existing bank line of credit, or 2) issue commercial paper through a special... View Details

Keywords: Financial Markets; Capital; Corporate Finance; Financial Services Industry

←
26
27
…
128
129
→